2-63056052-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_014562.4(OTX1):c.801G>A(p.Met267Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,613,240 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000096 ( 0 hom. )
Consequence
OTX1
NM_014562.4 missense
NM_014562.4 missense
Scores
2
10
7
Clinical Significance
Conservation
PhyloP100: 6.67
Genes affected
OTX1 (HGNC:8521): (orthodenticle homeobox 1) This gene encodes a member of the bicoid sub-family of homeodomain-containing transcription factors. The encoded protein acts as a transcription factor and may play a role in brain and sensory organ development. A similar protein in mouse is required for proper brain and sensory organ development and can cause epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 6 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTX1 | NM_014562.4 | c.801G>A | p.Met267Ile | missense_variant | 5/5 | ENST00000282549.7 | NP_055377.1 | |
OTX1 | NM_001199770.2 | c.801G>A | p.Met267Ile | missense_variant | 5/5 | NP_001186699.1 | ||
OTX1 | NR_130153.2 | n.1164G>A | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTX1 | ENST00000282549.7 | c.801G>A | p.Met267Ile | missense_variant | 5/5 | 1 | NM_014562.4 | ENSP00000282549.2 | ||
OTX1 | ENST00000366671.7 | c.801G>A | p.Met267Ile | missense_variant | 5/5 | 3 | ENSP00000355631.3 | |||
OTX1 | ENST00000405984.8 | n.*610G>A | non_coding_transcript_exon_variant | 5/5 | 2 | ENSP00000385782.4 | ||||
OTX1 | ENST00000405984.8 | n.*610G>A | 3_prime_UTR_variant | 5/5 | 2 | ENSP00000385782.4 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152004Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152004
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249524Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135040
GnomAD3 exomes
AF:
AC:
1
AN:
249524
Hom.:
AF XY:
AC XY:
0
AN XY:
135040
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461236Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726906
GnomAD4 exome
AF:
AC:
14
AN:
1461236
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
726906
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74232
GnomAD4 genome
AF:
AC:
6
AN:
152004
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74232
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 08, 2024 | The c.801G>A (p.M267I) alteration is located in exon 5 (coding exon 3) of the OTX1 gene. This alteration results from a G to A substitution at nucleotide position 801, causing the methionine (M) at amino acid position 267 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Pathogenic
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MutPred
Loss of glycosylation at P269 (P = 0.0887);Loss of glycosylation at P269 (P = 0.0887);
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at